ABSTRACT
2ϩ , Co 2ϩ , Ni 2ϩ , Pb 2ϩ , and Zn 2ϩ ) were examined on TREK-2 expressed in Xenopus oocytes using the two-electrode voltage clamping technique. Pb 2ϩ inhibited TREK channel activity (IC 50 ϭ 15.6 M), whereas Zn 2ϩ enhanced it in a dose-dependent manner (EC 50 ϭ 87.1 M). Ba 2ϩ slightly inhibited TREK currents but only at high concentrations. Co 2ϩ and Ni 2ϩ had no significant effect. The structural element (s) contributing to the zinc enhancement effect were studied using a series of chimeras consisting of Zn 2ϩ -activated TREK-2 and Zn 2ϩ -inhibited TWIK-related acid-sensing K ϩ channel-3. The structural elements were localized to the first pore and the preceding extracellular loop of TREK-2, in which multiple residues, including His121, His156, Asp158, and Asn177, are likely to be involved in the zinc activation effect. Stimulation by Zn 2ϩ may be used as a criterion of TREK-2, distinguishing it from other two-pore K ϩ channels.
The tandem-pore K ϩ channels have four transmembrane segments and two pore-forming domains in tandem. Because the two-pore K ϩ channels are open at resting membrane potential, they are thought to contribute to setting the resting membrane potential in excitable and nonexcitable cells. An increase in the activity of the channels can reduce neuronal excitability by hyperpolarizing membrane potential or by reducing the frequency and duration of action potentials. In contrast, a decrease in activity may increase the frequency and duration of action potentials, resulting in enhancing neuronal excitability. Two-pore channels can be differentially modulated by diverse factors including membrane stretching, unsaturated fatty acids, acidic conditions, and volatile anesthetics. The two-pore channels are thought to play protective roles in pathological conditions such as ischemia, acidosis, and stroke Kim, 2003; Talley et al., 2003) .
Molecular studies have revealed that two-pore K ϩ channels fall into six subgroups: 1) TWIK channels, consisting of TWIK-1 and TWIK-2; 2) TASK channels consisting of TASK-1, TASK-3, and TASK-5; 3) TALK channels, consisting of TALK-1, TALK-2, and TASK-2; 4) TRAAK/TREK channels, consisting of TREK-1, TREK-2, and TRAAK; 5) THIK channels, consisting of THIK-1 and THIK-2; and 6) TRESK channels, consisting of TRESK-1 and TRESK-2. Reconstitution of these channels in expression systems has allowed their individual biophysical and pharmacological properties to be characterized (Kim, 2003; Talley et al., 2003; Franks and Honore, 2004; Kang et al., 2004) .
TREK channels generate outwardly rectifying currents that are increased by unsaturated fatty acids such as arachidonic acid and mechanical stimuli such as cell swelling, stretch, and positive and negative pressure (Fink et al., 1996; Maingret et al., 1999; Bang et al., 2000) . In contrast to voltage-activated K ϩ channels, TREK and other two-pore channels are insensitive to traditional K ϩ channel blockers such as tetraethylammonium and barium (Ba 2ϩ ) (Kim, 2003) . Anesthetics and neuroprotective agents are reported to modulate some two-pore channels, which could therefore be targets for anesthesia and neuroprotection. However, the physiological role of two-pore channels needs to be further investigated, because their reported drug responses are different on distinct K ϩ channels. For example, the neuroprotective agents riluzole and sipatrigine affect TREK channels in opposite ways: riluzole activates TREK-1 and TRAAK, whereas sipatrigine inhibits them. In addition, TREK-1 and TREK-2 are activated by volatile anesthetics such as halothane and isoflurane, whereas TRAAK is not . Thus the effects of these drugs are not well enough understood to permit definitive characterization of the physiological functions of the TREK channels (Patel et al., 1998; Maingret et al., 1999; Kim et al., 2001) , and specific modulators of the various TREKs are needed.
In the present study, we compared the effects of several metal ions on human TREK-2 channels (Gu et al., 2002) . It turned out that TREK-2 currents were differentially affected by metallic ions; there was potent inhibition by Pb 2ϩ , dosedependent stimulation by Zn 2ϩ , and little effect of the other metal ions. We investigated the structural elements in TREK-2 responsible for Zn 2ϩ enhancement using a series of chimeras between Zn 2ϩ -activated TREK-2 and Zn 2ϩ -inhibited TASK-3. These studies suggested that structures including the first pore and its adjacent extracellular loop contribute to the Zn 2ϩ -mediated enhancement of TREK-2.
Materials and Methods
Chemicals. All the chemicals, including CoCl 2 , NiCl 2 , PbCl 2 , and ZnCl 2 , were purchased from Sigma-Aldrich (St. Louis, MO).
Cloning of Human TREK-2 and TASK-3 cDNAs. The firststrand cDNA was synthesized from 0.5 g of human brain Total RNA (Invitrogen, Carlsbad, CA) with avian myeloblastosis virus reverse transcriptase (Roche Diagnostics, Indianapolis, IN) by incubating at 42°C for 50 min. The reaction was terminated by heating at 95°C for 5 min. PCR primers were designed from human TREK-2 and TASK-3 sequences (GenBank accession numbers AF385400 and AF212829). The forward and reverse primers for human TREK-2 cDNA were 5Ј-TCTGGGCAACGAAGCA-3Ј and 5Ј-AAGCTTGCATT-GTCAGCATCAA-3Ј and for human TASK-3 cDNA were 5Ј-TGGCG-GCCATGAAGAGGCA-3Ј and 5Ј-TTTAAACGGACTTCCGGCGTT-3Ј. The PCR reaction protocol was denaturation at 95°C for 1 min, followed by 30 cycles of 95°C for 30 s, 54°C for 30 s, and 72°C for 2 min 30 s. PCR products were purified and ligated into TOPO TA vector (Invitrogen). They were identical in sequence to the open reading frames of human TREK-2 and TASK-3 (GenBank accession numbers AF385400 and AF212829), and were subcloned in pGEM-HEA to improve expression in Xenopus oocytes (Lee et al., 1999b) .
Construction of Chimeric Channel Proteins and TREK-2 Mutants. Five chimeras were created by introducing the corresponding regions of TASK-3 into TREK-2 as follows (where the subscripts refer to the regions of TREK-2 substituted): TREK M1M2, TREK M3M4 , TREK P1 , TREK P1a , and TREK P1b . The structure of each chimera is shown schematically in Fig. 3 . All chimeras were made using a standard PCR overlap extension method (Horton et al., 1989) . For TREK M1M2 , amino acids 1 to 221 of TREK-2 were replaced by residues 1 to 143 of TASK-3. For TREK M3M4 , residues 222 to 506 of TREK-2 were replaced by residues 144 to 374 of TASK-3. For TREK P1 , residues 95 to 171 of TREK-2 were replaced by residues 31 to 97 of TASK-3. For TREK P1a , residues 95 to 153 of TREK-2 were replaced by residues 31 to 79 of TASK-3, and for TREK P1b , residues 154 to 171 of TREK-2 were replaced by residues 80 to 97 of TASK-3. TREK-2 mutants (H121A, H135A, H156A, D158A, N177A, and N177H) with single-point mutations were made by the PCR overlap extension method (Horton et al., 1989) , and the mutated regions were confirmed by sequencing.
Expression of TREK-2, TASK-3, and Their Mutants in Xenopus Oocytes. Transcripts were synthesized in vitro using T7 RNA polymerase according to the protocol supplied by the manufacturers (Ambion, Austin, TX), after linearizing the cDNA constructs with AflII. Xenopus oocytes were prepared from female Xenopus laevis frogs (Xenopus One, Ann Arbor, MI), as described previously (Lee et al., 1999a) . The oocytes were injected with 0.5 to 1 ng of cRNA of TREK-2 or TREK-2-like chimeric channels showing activation to zinc, and with 2 ng of cRNA of TASK-3 or TASK-3-like chimeric channels showing inhibition to zinc, using a Drummond Nanoject injector (Drummond Scientific Company, Parkway, PA). For TREK-2 mutants with single-point mutations, 1 ng of cRNA was injected into oocytes to compare their relative expression levels. There was no significant difference between current amplitudes of the mutant channels.
Electrophysiological Recordings and Data Analysis. K ϩ currents were measured in SOS solution (2 mM KCl, 100 mM NaCl, 1.8 mM CaCl 2 , 1 mM MgCl 2 , 5 mM HEPES, 2.5 mM pyruvic acid, and 50 g/ml gentamicin, pH 7.4) using a voltage-clamp amplifier (OC-725C; Warner Instruments, Hamden, CT). Serial zinc solutions were prepared just before experiments by diluting a stock solution of 10 mM ZnCl 2 that was made in slightly acidified SOS, and then diluted zinc solutions were readjusted to pH 7.4 with NaOH. Microelectrodes (Warner Instruments) were filled with 3 M KCl, and their resistances were 0.2 to 1.0 M⍀. The currents were sampled at 5 kHz and low-pass filtered at 1 kHz using the pClamp system (Digidata 1320A and pClamp 8; Axon Instruments, Foster City, CA). Peak currents were analyzed with Clampfit software (Axon Instruments), and graphical representations of the data were obtained with Prism software (GraphPad, San Diego, CA). Dose-response curves were fitted to the Hill equation
, where B is the normalized block, EC 50 is the concentration of a divalent ion giving half-maximal enhancement, and n is the Hill coefficient. The concentration of a divalent ion giving half-maximal inhibition is represented as IC 50 . Data are presented as means Ϯ S.E.M. and tested for significance using Student's unpaired t test.
Results
The membrane potential of untreated or water-injected oocytes was Ϫ22 Ϯ 3 mV in SOS solution containing 2 mM K ϩ (n ϭ 12). We first examined the endogenous K ϩ currents evoked by a series of test potentials from Ϫ120 to ϩ20 mV from a holding potential of Ϫ90 mV. The currents detected were less than 100 nA even at ϩ20 mV ( Fig. 1 , A and C). In contrast, the membrane potential of oocytes injected with TREK-2 cRNA was Ϫ82 Ϯ 4 mV in SOS solution (n ϭ 20; Fig.  1C ). This hyperpolarization suggests that TREK-2 plays a pivotal role in setting resting membrane potential in cells in which these channels are expressed. Expression of TREK-2 was also evident from the robust outward K ϩ currents evoked by depolarizing potentials from a holding potential of Ϫ90 mV (Fig. 1B) . These results suggest that the relatively small current amplitude of the endogenous K ϩ currents should have little effect on the biophysical properties of the recombinant TREK-2 currents.
We examined the effects of divalent metal ions on outward K ϩ currents evoked every 10 s by applying test pulses to Ϫ20 mV from a holding potential of Ϫ90 mV. Perfusion of low concentrations of Ba 2ϩ (10, 30, and 100 M) had no effect on the TREK-2 currents, and 300 M Ba 2ϩ only decreased them by about 10 Ϯ 5% (Fig. 1D) . Meanwhile, application of concentrations of Ni 2ϩ or Co 2ϩ up to 300 M had no effect (Fig. 1, E and F) . Among the metal ions examined, only lead (Pb 2ϩ ) caused substantial inhibition (IC 50 ϭ 15.6 Ϯ 1.5 M; Fig.  1G ), but there was no significant effect of test potential on the extent of inhibition (Fig. 1H ). The effects of divalent metal ions were further examined by comparing activation rates of TREK-2 currents before and after application of the ions. The Enhancement of Human TREK-2 Currents by Zinc fast time constant ( fast ) of TREK-2 activation was not significantly changed by any of the divalent ions examined; however, the slow time constant ( slow ) was increased by barium but not by the other metal ions (Fig. 1, I and J).
The application of Zn 2ϩ increased the TREK-2 currents in a dose-dependent manner (Fig. 2, A and B) . The effect was immediate and usually saturated in ϳ1.5 min (Fig. 2B) . A similar effect of Zn 2ϩ was observed on TREK-2 currents evoked by a ramp protocol (Fig. 2C) . Curve fitting gave an EC 50 of 87.1 Ϯ 3.1 M and a Hill coefficient n of 1.1 Ϯ 0.2 (Fig. 2D ). EC 50 values at different potentials were similar. Consistent with this, the values for percentage of stimulation of TREK-2 currents by 100 M zinc were not significantly changed at different test potentials (Fig. 2I) , suggesting that Zn 2ϩ activation is voltage-independent. The activation time constants fast and slow of the TREK-2 currents tended to be diminished by Zn 2ϩ , but the differences were not significant (Fig. 2 , G and H; P Ͼ 0.05, Student's t tests).
A key question concerning the Zn 2ϩ effect relates to the structural element(s) in TREK-2 that are responsible. To throw light on this question, we constructed a series of chimeras between Zn 2ϩ -activated TREK-2 and zinc-inhibited TASK-3 (Clarke et al., 2004) cloned from human brain RNA by RT-PCR (see Materials and Methods) . Expression of pure TASK-3 channels generated strong outward currents in response to depolarizing potentials, and Zn 2ϩ inhibited these currents (IC 50 ϭ 25.4 Ϯ 1.2 M, Hill coefficient ϭ 1.0 Ϯ 0.1, Fig. 2 , E and F). The activation time constants ( fast and slow ) of TASK-3 were elevated by 100 and 1000 M Zn 2ϩ (Fig. 2 , G and H; P Ͻ 0.01, 0.05, Student's t test). The percentage of inhibition of the TASK-3 currents by 100 M Zn 2ϩ was similar at different potentials, suggesting that Zn 2ϩ inhibition of TASK-3 is voltage-independent (Fig. 2I) .
To help identify the site(s) modulated by Zn 2ϩ , chimeras were first constructed by substituting either the N-terminal or C-terminal halves of TREK-2 with the corresponding regions of TASK-3. Expression of TREK M1M2 (first half of TREK-2 replaced with that of TASK-3), gave strong outward currents inhibited by Zn 2ϩ (IC 50 ϭ 27.7 Ϯ 2.0 M; Fig. 3B ). The TREK M1M2 currents were activated instantaneously in response to step test potentials; consequently, the activation kinetics were not properly fitted by exponential equations. Apparently, the replacement of the first half of TREK-2 with that of TASK-3 creates a chimera that is activated much faster than wild-type TREK-2 or TASK-3.
In contrast, expression of TREK M3M4 (second half of TREK-2 replaced with that of TASK-3) did not generate significant outward currents so that we could not evaluate the effect of Zn 2ϩ ions (Fig. 3C) . However, the fact that the Zn 2ϩ sensitivity of the first-half chimera (TREK M1M2 ) resembled that of TASK-3 suggests that the N-terminal half of (asterisk) of a 300-M metal ion solution are overlapped to show the effect of each metal ion on TREK-2. The vertical bars in the insets represent 1 A. Data are represented as means Ϯ S.E.M. (n ϭ 6 -8). The smooth curve for Pb 2ϩ blockade was fitted using the Hill equation (see Materials and Methods). The estimated IC 50 of Pb 2ϩ on the TREK-2 current is 15.6 Ϯ 1.5 M (n ϭ 6). Inhibition percentages of TREK-2 currents by 30 M Pb 2ϩ were plotted against potentials (H; n ϭ 6). The activation time constants ( fast and slow ) of TREK-2 currents were obtained from fitting each current trace with two-exponential curves, and their average values were plotted against concentrations (I and J). Except for Ba 2ϩ , the other metal ions did not change activation time constants significantly (n ϭ 6 -8). ϩ currents (A) and human recombinant TREK-2 currents (B) were recorded from oocytes in which H 2 O and TREK-2 cRNA was injected, respectively. Currents were evoked by a series of step potentials ranging from Ϫ120 to ϩ20 mV, from a holding potential of Ϫ90 mV. The average current-voltage relationships of native K ϩ channels and TREK-2 channels were plotted (C; n ϭ 12 and 20). K ϩ currents through TREK-2 were evoked by test potentials to Ϫ20 mV for 200 ms from a holding potential of Ϫ90 mV to examine the effects of divalent metal ions on TREK-2. Currents were recorded every 10 s with 2 mM K ϩ as charge carrier in the presence and absence of increasing concentrations of Ba TREK-2 plays an important role in controlling the enhancement by Zn 2ϩ . We further dissected the first half of TREK-2 to localize the element(s) influencing the Zn 2ϩ enhancement effect. Our hypothesis was that the first pore and/or its neighboring extracellular loop would be more important for the Zn 2ϩ effect than the transmembrane or cytoplasmic loops. Accordingly, we constructed TREK P1 (the first-pore loop and preceding extracellular loop of TREK-2 replaced by those of TASK-3) and examined its response to Zn 2ϩ . Superfusion of Zn 2ϩ solution inhibited channel activity ( Fig. 3D ) with an IC 50 of 12.6 Ϯ 2.1 M, about 2-fold lower than that for TASK-3. These data support the idea that the first pore and the preceding extracellular loop are responsible for the opposing effects of Zn 2ϩ on TREK-2 and TASK-3. The reason why substitution of the TASK-3 regions actually renders TREK P1 more sensitive to Zn 2ϩ than TASK-3 itself remains to be investigated.
To further localize the key controlling structures, we constructed TREK P1a and TREK P1b (the extracellular loop and first pore of TREK-2, respectively, replaced by the corresponding regions of TASK-3) (Fig. 3, E and F) . Zn 2ϩ inhibited the activity of TREK P1a with an IC 50 of 32.6 Ϯ 2.6 M, whereas 58% of TREK P1a activity was maintained at 1000 M zinc (Fig. 3E) . These results indicate that introduction of the extracellular loop of TASK-3 causes TREK P1a to be partially inhibited by Zn 2ϩ rather than strongly enhanced by it. It also implies that the extracellular loop of TREK-2 contributes to the Zn 2ϩ modulation effect. The outcome with the other chimera TREK P1b was similar, with an IC 50 of 29.6 Ϯ . The TREK-2 currents have been normalized to the control current before application of Zn 2ϩ and then the normalized current amplitude (-fold) plotted against time (s). C, the Zn 2ϩ enhancement effect on the TREK-2 current is voltage-independent. TREK-2 currents were evoked by a ramp protocol with potential changed from Ϫ120 to ϩ20 mV for 200 ms. Stimulation of the TREK-2 current by Zn 2ϩ was essentially voltage-independent. D, dose-response curve of the Zn 2ϩ enhancement of TREK-2. Peak TREK-2 currents were normalized to the control currents in the absence of Zn 2ϩ , and the -fold stimulation is plotted against Zn 2ϩ concentration. The smooth curve was obtained by fitting the data using the Hill equation. The estimated EC 50 of TREK-2 is 87.1 Ϯ 3.1 M, and a Hill coefficient is 1.1 Ϯ 0.2 (means Ϯ S.E.M., n ϭ 8). E, Zn 2ϩ inhibition of TASK-3 currents. The voltage protocol used in Fig. 2A was applied to elicit TASK-3 currents every 10 s, and the currents before and after application of Zn 2ϩ are overlapped. F, dose-response curve of the Zn 2ϩ inhibition of TASK-3. The smooth curves were obtained by fitting data using the Hill equation. The estimated IC 50 and Hill coefficient of Zn 2ϩ inhibition on TASK-3 currents is 25.4 Ϯ 1.2 M and 1.0 Ϯ 0.1 (n ϭ 6). G and H, the activation time constants ( fast and slow ) of TREK-2 (F) and TASK-3 (E) currents were obtained from fitting them with two-exponential curves and then plotted against zinc concentrations (n ϭ 8 and 6, respectively). I, voltage dependence of TREK-2 (F) activation and TASK-3 (E) inhibition by 100 M zinc was shown by plotting their average percent values against test potentials (n ϭ 8 and 6, respectively). (Fig. 3F) . Incomplete inhibition (ϳ34%) at more than 1000 M Zn 2ϩ was also found with TREK P1b . The levels of residual inhibition in TREK P1a and TREK P1b suggest that the first pore is more important than the intracellular loop for the enhancement of TREK-2 channel activity by Zn 2ϩ . The activation time constants ( fast and slow ) of the chimeric channels are shown as a function of Zn 2ϩ concentration in Fig. 3G . No significant difference was found between the fast activation time constants of the chimeras in either the presence or absence of Zn 2ϩ . The slow activation constants of the three mutant channels in the absence of Zn 2ϩ were similar and significantly lower than that of wild-type TREK-2 (P Ͻ 0.05, Student's t test; Figs. 2H and 3G) . The slow constants of TREK P1 and TREK P1b were increased by Zn 2ϩ , whereas that of TREK P1a was unaffected (Fig. 3G) .
Enhancement of Human TREK-2 Currents by
Zn 2ϩ can interact with histidine and cysteine residues and Fig. 3 . Effect of Zn 2ϩ on chimeras of the TREK-2 and TASK-3 channels. A, schematic diagrams of TREK-2 and TASK-3. White cylinders and thin lines indicate regions derived from TREK-2; gray cylinders and thick lines are those derived from TASK-3. P1 between M1 and M2 is divided into two portions, the extracellular loop (P1a) and the first pore (P1b), and P2 between M3 and M4 is the second pore (see Materials and Methods). B through F, Zn 2ϩ inhibition profiles of TREK M1M2 (B, F), TREK M3M4 (C), TREK P1 (D, E), TREK P1a (E, OE), and TREK P1b (F, ‚). In the left panels are schematic diagrams of the chimeras. In the middle panels, representative currents of each chimera recorded in the absence (control) and presence of serial concentrations of Zn 2ϩ are overlapped. All the currents were evoked by the same voltage protocol every 10 s. Vertical bars represent 1 A. In the right panels, all the currents are normalized to the control current recorded in the absence of Zn 2ϩ and plotted against the applied Zn 2ϩ concentration. The smooth curves were fitted using the Hill equation. The estimated IC 50 values of TREK M1M2 , TREK P1 , TREK P1a , and TREK P1b are 27.7 Ϯ 2.0, 12.6 Ϯ 2.1, 32.6 Ϯ 2.0, and 29.6 Ϯ 2.2 M, and their Hill coefficients are 1.5 Ϯ 0.06, 1.0 Ϯ 0.07, 1.2 Ϯ 0.19, and 1.3 Ϯ 0.1, respectively (n ϭ 5-7). C, no functional expression of TREK M3M4 was detected. G, activation time constants of chimeric channels. Chimeric channel currents were fitted with two exponential curves, and their fast and slow time constants ( fast and slow ) were plotted against zinc concentrations (n ϭ 4 -6).
the acidic amino acids aspartic acid and glutamic acid. These types of residue are present in the extracellular loop; we examined the roles of the three histidine residues (His121, His135, and His156) by replacing them individually with alanine. TREK H121A activity was increased by 10 M Zn 2ϩ and somewhat further by 100 M Zn 2ϩ . Thereafter, there was partial inhibition by 1000 M Zn 2ϩ , with activity dropping to about the level produced by 10 M zinc. Similarly, TREK H156A activity was enhanced by 10 M Zn 2ϩ but was not further increased by 100 M Zn 2ϩ and was partially inhibited by 1000 M Zn 2ϩ (Fig. 4B) ; the level of the inhibited activity tended to be slightly lower than the control activity in the absence of Zn 2ϩ . These biphasic profiles suggest that His121 and His156 in the extrafascial loop contribute to activation by Zn 2ϩ . Unlike TREK H121A and TREK H156A , however, TREK H135A was activated by Zn 2ϩ , and its activation profile was similar to that of wild-type TREK-2. Therefore, of the three histidine residues, His121 and His156 seem to be critical for Zn 2ϩ activation. In the first-pore region, we selected Asp158 and Asn177 (asparagine177) and individually mutated them to alanine, because Asp158, an acidic amino acid, was recently reported to play a role in Cu 2ϩ activation of TREK-1 (Gruss et al., 2004) , and Asn177 corresponds to His98 of TASK-3, which is essential for Zn 2ϩ inhibition of TASK-3 (Clarke et al., 2004) . TREK D158A activity was stimulated by Zn 2ϩ up to 100 M, and its Zn 2ϩ activation profile was similar to that of wild-type TREK-2 over that range. However, there was no further activation but rather slight inhibition by 1000 M Zn 2ϩ
. The -fold activations of TREK D158A by 100 and 1000 M Zn 2ϩ were greater than those of TREK H121A or TREK H156A . Nevertheless, the partial inhibition of TREK D158A by 1000 M Zn 2ϩ suggests that Asp158 may participate in Zn 2ϩ activation of TREK-2, although it may be less important than His121 and His156. Similarly, the activities of TREK N177A and TREK N177H were stimulated by low concentrations of Zn 2ϩ up to 100 M and then partially inhibited by 1000 M Zn 2ϩ , and the -fold stimulations by 1000 M Zn 2ϩ were less than that of wild-type TREK-2 (P Ͻ 0.05, Student's t test; Fig. 4B ), implying that Asn177 also participates in Zn 2ϩ stimulation. These mutagenesis experiments suggest that multiple residues spreading across the extracellular loop and first pore contribute to Zn 2ϩ activation of TREK-2. Although His121 and His156 in the extracellular loop and Asp158 and Asn177 in the first pore contribute to Zn 2ϩ activation, we cannot rule out the possibility that residues in other regions contribute to the activation.
Discussion
We have compared the effects of various divalent metal ions on the human TREK-2 channel expressed in Xenopus   Fig. 4 . The effect of Zn 2ϩ on TREK-2 mutants. A, sequence alignment of human TREK-2, TREK-1, and TASK-3 in the extracellular loop (P1a) and the first pore (P1b). The histidine residues in bold, His121, His135, and His156 in the extracellular loop of TREK-2, were individually mutated to alanine. In the pore region underlined, Asp158 of TREK-2 was mutated to alanine, and Asp177 was mutated to alanine or histidine. B, the effect of Zn 2ϩ on TREK H121A (Ⅺ), TREK H135A (f), TREK H156A (E), TREK D158A (F), TREK N177A (‚), and TREK N177H (OE). Currents through the mutant channels were evoked by application of Ϫ20 mV from a holding potential of Ϫ90 mV every 10 s. Representative current traces of individual mutant channels before and after application of serial zinc solutions were displayed, and normalized current amplitudes are plotted against Zn 2ϩ concentrations. Data represent means Ϯ S.E.M. (n ϭ 4 -8). C, activation time constants of mutant channel currents before and after application of serial zinc solutions. Activation of each current was fitted with double exponential curves, and activation time constants ( fast and slow ) were plotted (n ϭ 4 -8). oocytes. Of the metal ions, only Zn 2ϩ enhanced channel activity. Examination of chimeras of TREK-2 and TASK-3, which are affected in opposite directions by Zn 2ϩ , showed that structural elements in the extracellular loop and first pore are involved in Zn 2ϩ stimulation. Substitution of His121 and His156 in the extracellular loop and of Asp158 and Asn177 in the first pore rendered the dose-dependent enhancement effect somewhat biphasic, with less activation at higher Zn 2ϩ concentrations. This indicates that His121, His156, Asp158, and Asn177 contribute to Zn 2ϩ activation. However, none of the substitutions totally abolished TREK-2 channel stimulation by Zn 2ϩ . Using the information obtained concerning the role of these residues, we attempted to abolish Zn 2ϩ activation of TREK-2 or convert it to Zn 2ϩ inhibition by introducing additional single-point mutation(s). Mutation of Asn177 in the pore to histidine, the corresponding residue in TASK-3, gave a biphasic modulation effect similar to that with N177A. In addition, even when H156A and N177A were combined, the Zn 2ϩ modulation profile resembled that of H156A and N177A. Furthermore, His121 and His156 are identical to the residues in the TREK-1 channel (Fig. 4A) , which is reported to be inhibited by Zn 2ϩ (Gruss et al., 2004) . These findings suggest that the zinc activation effect is not due to one or two residues, but that multiple residues including the four residues identified here and unidentified residues are likely to be jointly responsible. For example, negatively charged residues (Asp and Glu) in the extracellular loop could be also targets for the effect of Zn 2ϩ . Therefore, it will be of interest to establish how a number of different residues interact to bring about Zn 2ϩ activation. Structure-function studies of TREK and other two-pore channels have revealed the critical regions required for sensitivity to free fatty acids and pH by analyzing deletion mutants and chimeric channels (Kim, 2003; Franks and Honore, 2004) . The initial 30-amino acid regions of the carboxyl termini of TREK-1 and TREK-2 were identified as crucial for activation by free fatty acids and protons. A glutamate residue in the region was shown to play a role as a proton sensor that also affects the sensitivity to mechanic stimuli and free fatty acids. The same C-terminal region of TREK-1 was shown to participate in its activation by volatile anesthetics such as halothane. In contrast to the carboxyl termini involved in sensitivity to pH and fatty acids, the regions affected by divalent ions were localized to the firstpore segment and the preceding extrafascial loop. Glu70 in the extrafascial loop of TASK-1 was shown to be critical for inhibition by ruthenium red (Czirjak and Enyedz, 2003) . In the case of TASK-3, Glu70 in the extrafascial loop and His98 in the first pore were critical for zinc inhibition (Gruss et al., 2004) . These results, in combination with our findings, suggest that the extracellular loop and the first pore contain key motif(s) participating in the modulation of two-pore K ϩ channel activity by endogenous trace ions such as Zn 2ϩ and Cu 2ϩ . Therefore, these regions are potential targets for drugs regulating two-pore channel activity.
Enhancement of Human TREK-2 Currents by
Like TREK-2, acid-sensing ion channels and ATP-sensitive K ϩ channels show Zn 2ϩ -mediated activation (Baron et al., 2001; Prost et al., 2004) . Zn 2ϩ potentiates acid-sensing channels activated by protons, and the Zn 2ϩ -interacting sites were identified as His163 and His339 in the extracellular loop located just after the first trans-membrane domain.
Zn 2ϩ activates ATP-sensitive K ϩ channels by interacting with extracellular His326 and His332 of the sulfonylurea receptor subunit (Bancila et al., 2005) . Although issues such as Zn 2ϩ -interacting sites have been solved, it still remains to be determined how Zn 2ϩ activates channels. For example, it may modulate either the number of channels in the membrane, their single-channel conductance, or their probability of opening. Single-channel recordings in the outside-out configuration might distinguish between these possibilities. In the case of Shaker-and Shaw-type K ϩ channels, Zn 2ϩ activates channel activity by increasing subunit tetramerization (Jahng et al., 2002; Strang et al., 2003) . Therefore, the question of whether the Zn 2ϩ activation effect on TREK-2 is correlated with dimerization of its subunits should be tested by biochemical approaches. Cu 2ϩ has been shown to activate TREK-1 (Gruss et al., 2004) , and Asp128 plays a critical role in this effect. Therefore, we have tested whether Cu 2ϩ stimulates TREK-2 activity. Application of Cu 2ϩ led to activation of TREK-2 with an activation profile similar to that of Zn 2ϩ (J. S. Kim, H. Bang, and J.-H. Lee, unpublished data).
In the brain, Zn 2ϩ is stored in synaptic vesicles and released from presynaptic terminals by depolarization (Howell et al., 1984; Ebadi et al., 1994) . The released Zn 2ϩ reaches a concentration exceeding 100 M upon strong synaptic activation and interacts with structures such as ion channels and ligand-gated receptors to modulate synaptic transmission and neuronal excitability. Hence, TREK-2 may be one of the targets modulated by elevated Zn 2ϩ concentrations. The Zn 2ϩ activation effect could be a mechanism by which Zn 2ϩ modulates neuronal excitability. In addition, it may help, together with other factors such as membrane stretching, unsaturated fatty acids, and hydrogen ions, to protect neurons from damage under pathological conditions by attenuating neuronal excitability. Conversely, Zn 2ϩ deficiency may depolarize the membranes of neuronal cells expressing TREK-2, thus aggravating the damage to them under pathological conditions by increasing their excitability.
Unlike Zn 2ϩ , Pb 2ϩ proved to be a strong inhibitor of TREK-2 activity, whereas Co 2ϩ and Ni 2ϩ had no effect (Fig.  1) . Pb 2ϩ blocks voltage-gated Ca 2ϩ and K ϩ channels and hyperpolarization-activated channels but activates SK4, a Ca 2ϩ -activated K ϩ channel, by acting as a Ca 2ϩ surrogate. These findings suggest that Pb 2ϩ acts differently on different ion channels (Cao and Houamed, 1999; Atchison, 2003; Dai et al., 2003; Liang et al., 2004) . Therefore, its effects may differ between different types of two-pore K ϩ channels. Together with the absence of effect of Co 2ϩ and Ni 2ϩ , the effect of Pb 2ϩ might be used to distinguish TREK-2 from other two-pore K ϩ channels. Recently, Clarke et al. (2004) showed that Zn 2ϩ strongly inhibits human TASK-3 with an IC 50 ϭ 19.8 M but has no effect on human TASK-1 and TASK-2. Gruss et al. (2004) have also shown that Zn 2ϩ inhibits TASK-3, with an IC 50 ϭ 12.7 M, and that the IC 50 for TREK-1 was 659 M. In the light of these reports and our findings, it seems that the effect of Zn 2ϩ could be used as a criterion to distinguish TREK-2 from TREK-1 and other two-pore channels, although the effect of Zn 2ϩ on other two-pore K ϩ channels remains to be investigated. In addition, the results reported here provide a basis for exploring the pore structure and function of twopore potassium channels. 
